Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

CONTRIBUTING WRITER

Deepak Balak, MD, MSc
Erasmus MC, Department of Dermatology
Utrecht, Netherlands

Dr. Balak works as a dermatologist at the Department of Dermatology and Allergology of the University Medical Center Utrecht in Utrecht, the Netherlands, where he combines patient care with teaching responsibilities and research. His clinical interests are centered on the impact and management of inflammatory and autoimmune diseases. His scientific interests include translational medicine, clinical drug development, and evaluation in the field of chronic immune-mediated inflammatory skin diseases, such as psoriasis. As a 2019 Fellow, he will study with Dr. Alice Gottlieb at the Mount Sinai Hospital in New York, New York and attend the European Academy of Dermatology and Venereology Congress.

Last Updated: Nov 20, 2019

Latest news

January 06, 2021
Recently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19 statement after an in-depth analysis of publicly available data with two currently approved anti-SARS-CoV-2 vaccines in the US, both mRNA-based.
December 02, 2020
While the news of a potential SARS-CoV-2 vaccine is to be welcomed, the impact of psoriasis therapy, particularly systemic therapy, on the effectiveness and safety of vaccines needs to be considered.
November 19, 2020
Get the latest updates about psoriasis on topics such as pathogenesis, markers and therapeutics from Dr. Mohamed El-Komy in this short IPC video.
November 03, 2020
Get the latest news on treating psoriasis in the Middle East with Dr. El Sayed.
  More News

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK